Outcome
    Strong Evidence

    Vitamin D for Lung Function

    Vitamin D reduces acute respiratory infection risk — with the largest protective effect in people who are deficient — and supports antimicrobial lung defenses.

    Overview

    Vitamin D and lung function is a story about exacerbations, not about spirometry numbers.
    The strongest signal comes from asthma: individual participant data meta-analyses of randomised trials show that vitamin D reduces the rate of exacerbations requiring systemic corticosteroids, with the benefit concentrated in participants who were deficient at baseline. Later large trials in unselected populations have been less impressive, reinforcing that this is deficiency correction rather than enhancement. What vitamin D does not reliably do is improve measured lung function. FEV1 and FVC generally do not change meaningfully in trials, in asthma or COPD. Someone hoping to breathe better on spirometry is likely to be disappointed; someone deficient with frequent asthma attacks may have fewer of them.

    No studies are currently linked to this pairing

    This page reflects published clinical literature and conventional dosing rather than trial data attached to this outcome in our library.

    How It Works

    Airway disease combines chronic inflammation, structural remodelling and susceptibility to respiratory infections that trigger exacerbations. Most acute deteriorations in asthma and COPD are precipitated by viral or bacterial infection, which is where vitamin D plausibly acts.
    Airway epithelial cells express the vitamin D receptor and CYP27B1, generating active calcitriol locally. This induces cathelicidin and other antimicrobial peptides, strengthens epithelial tight junctions, and modulates T cell responses towards regulatory phenotypes while dampening Th2 and Th17 inflammation. Vitamin D also influences corticosteroid responsiveness in laboratory models of steroid-resistant asthma. None of these mechanisms reverse fixed airflow obstruction. Structural remodelling, emphysema and smoking-related damage are not reversible by a nutrient, which is consistent with the flat spirometry results.

    Dosing & Protocol

    Daily dosing, targeted at those with low levels.
    ContextDoseFormTiming
    Maintenance1000-2000 IU dailyCholecalciferol (D3)With a fat-containing meal
    Correcting deficiency3000-4000 IU dailyCholecalciferolUnder guidance, retest at 3 months
    Asthma trial regimensTypically daily or weekly dosingCholecalciferolBolus regimens showed no exacerbation benefit
    Upper intake level4000 IU daily long termCholecalciferolHigher only with monitoring

    Inhalers come first

    Inhaled corticosteroids, bronchodilators, smoking cessation and pulmonary rehabilitation are the interventions that change respiratory outcomes. Vitamin D is an adjunct at best.

    Evidence

    There are currently no studies linked to this pairing in our library, so no study list is shown.
    Individual participant data meta-analyses of randomised asthma trials found reduced rates of exacerbations requiring systemic corticosteroids, with effects strongest in baseline-deficient participants. Parallel evidence shows daily vitamin D reduces acute respiratory infections, the main exacerbation trigger, and COPD meta-analyses suggest reduced exacerbations in severely deficient patients only. The limitations are substantial: subsequent large trials in vitamin D-replete asthma populations found no benefit, spirometry endpoints consistently show no improvement, symptom scores and quality of life rarely shift, and bolus dosing does not work. There is no evidence of benefit for healthy lungs or for interstitial lung disease.

    Fewer attacks in deficient patients; unchanged spirometry

    Exacerbation reduction is the supported endpoint, and only where baseline levels are low.

    Safety

    Vitamin D at 1000-4000 IU daily is safe for most adults. Excessive sustained intake causes hypercalcaemia, presenting as nausea, thirst, polyuria, confusion and kidney injury.

    Never reduce inhaled steroids because you started vitamin D

    Stopping preventer therapy is a leading cause of fatal asthma attacks. Worsening breathlessness, rescue inhaler use more than twice weekly, or night waking needs urgent medical review.

    Avoid high doses in sarcoidosis and tuberculosis - both lung conditions in which granulomatous macrophages activate vitamin D without regulation, causing hypercalcaemia. This is a genuinely relevant caution in respiratory practice. Caution also applies with primary hyperparathyroidism and calcium stone disease.

    Interactions & Conflicts

    Steroid therapy and granulomatous lung disease dominate the interaction picture.
    Interacts withSeverityMechanismAction
    Pulmonary sarcoidosis
    high
    		Granulomas activate vitamin D, causing hypercalcaemiaAvoid high doses; specialist supervision
    Oral corticosteroids
    moderate
    		Accelerate vitamin D catabolism and reduce bone densityHigher requirements; bone protection often needed
    Inhaled corticosteroids
    low
    		No adverse interaction; complementaryContinue as prescribed
    Smoking
    high
    		Dominant driver of lung function declineCessation outweighs any supplement
    Bolus dosing
    moderate
    		No exacerbation benefit in trialsUse daily dosing

    References

    No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.